Kirk Williamson, APRN
Nurse Practitioner · Jonesboro, ARNPI 1821449372
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,114 of the $8,118 with a category attached, or 87.6%. It is spread thinly across 31 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 440 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novartis$961
- Pfizer$931
- Johnson & Johnson$656
- Boehringer Ingelheim$568
- AstraZeneca$455
- plus $3K from 25 others
What the payments were for
- Travel & lodging$90511%
- Food & beverage$7,11488%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,152 |
| Novartis | 80 | $961 |
| Pfizer | 62 | $931 |
| Johnson & Johnson | 54 | $656 |
| Boehringer Ingelheim | 37 | $568 |
| AstraZeneca | 21 | $455 |
| Amgen | 32 | $431 |
| Abbott | 13 | $379 |
| Merck | 27 | $370 |
| Novo Nordisk | 19 | $365 |
| E.r. Squibb & Sons, L.L.C. | 15 | $280 |
| Esperion Therapeutics, Inc. | 9 | $253 |
| Alnylam Pharmaceuticals Inc. | 9 | $213 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $196 |
| Sanofi-aventis U.S. LLC | 7 | $138 |
| Organon | 1 | $132 |
| Lexicon Pharmaceuticals, Inc. | 6 | $98 |
| Bayer | 4 | $89 |
| Cvrx, Inc. | 4 | $85 |
| Inspire Medical Systems, Inc. | 2 | $62 |
| Edwards Lifesciences | 2 | $51 |
| Scpharmaceuticals Inc. | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Bridgebio Pharma, Inc. | 2 | $33 |
| Angiodynamics, Inc. | 1 | $27 |
| Boston Scientific | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Cordis US CORP. | 1 | $19 |
| Heartflow, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Atricure, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,118 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 333 | $282,969 |
| XareltoRivaroxaban | 132 | $84,192 |
| EntrestoSacubitril/Valsartan | 105 | $84,153 |
| JardianceEmpagliflozin | 77 | $51,731 |
| MultaqDronedarone Hcl | 31 | $35,000 |
| BrilintaTicagrelor | 21 | $16,390 |
| Repatha SureclickEvolocumab | 13 | $10,292 |
| Flecainide Acetate | 119 | $4,931 |
| Propafenone Hcl ErPropafenone Hcl | 25 | $4,262 |
| NexlizetBempedoic Acid/Ezetimibe | 11 | $4,210 |
| Ranolazine ErRanolazine | 45 | $3,964 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 123 | $3,336 |
| SotalolSotalol Hcl | 168 | $3,123 |
| Atorvastatin Calcium | 405 | $3,115 |
| Metoprolol Succinate | 212 | $2,316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $931 | $282,969333 claims |
| Johnson & JohnsonXarelto | $656 | $84,192132 claims |
| NovartisEntresto | $961 | $84,153105 claims |
| Boehringer IngelheimJardiance | $568 | $51,73177 claims |
| Sanofi-aventis U.S. LLCMultaq | $138 | $35,00031 claims |
| AstraZenecaBrilinta | $455 | $16,39021 claims |
| Esperion Therapeutics, Inc.Nexlizet | $253 | $4,21011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Jonesboro
- Angela JonesJonesboro$90K
- Rhonda HillJonesboro$20K
- Mandy GordonJonesboro$12K
- Brooke PruittJonesboro$7K
- Mary OharaJonesboro$6K
- Angie HolifieldJonesboro$4K
- Merideth HanksRogers$157K
- Tiffany McConathyHot Springs$54K
- Brenna FitzgeraldNorth Little Rock$46K
- Iris KennedyLittle Rock$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.